Related Experiment Videos
Is the dopaminergic system involved in the central effects of nicotine in mice?
1Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0613.
Abstract:
Pretreatment with ineffective doses of the D1 antagonist SCH23390 but not the D2 antagonist sulpiride reduced hyperactivity induced by nicotine in mice habituated to the test cage. On the other hand, the D1 and D2 antagonists were ineffective in blocking nicotine-induced hypoactivity in naive mice. Finally, SCH23390 and sulpiride did not block the antinociception induced by nicotine. Our data indicate that the dopamine receptors D1 and D2 are not involved in all the central effects of nicotine in mice, but seems to be a substrate for locomotor activation induced by nicotine under specific experimental conditions.
Insights
Dopamine D1 and D2 receptors are involved in nicotine-induced hyperactivity in mice under specific conditions. These receptors do not appear to mediate nicotine
Area of Science:
- Neuropharmacology
- Behavioral Neuroscience
- Dopaminergic System Research
Background:
- Nicotine, a psychoactive compound, exerts diverse central nervous system effects.
- The role of dopamine receptors in mediating nicotine's behavioral effects is complex and not fully elucidated.
- Previous research suggests potential involvement of dopamine pathways in nicotine's actions.
Purpose of the Study:
- To investigate the specific involvement of dopamine D1 and D2 receptors in mediating nicotine-induced locomotor activity and antinociception in mice.
- To determine if dopamine receptor antagonists can block behavioral changes induced by nicotine under different experimental conditions (habituation vs. naive).
Main Methods:
- Mice were habituated to a test cage before nicotine administration.
- Dopamine D1 antagonist (SCH23390) and D2 antagonist (sulpiride) were administered as pretreatments.
- Nicotine-induced hyperactivity, hypoactivity, and antinociception were measured and analyzed.
Main Results:
- Pretreatment with the D1 antagonist SCH23390, but not the D2 antagonist sulpiride, reduced nicotine-induced hyperactivity in habituated mice.
- Both D1 and D2 antagonists were ineffective in blocking nicotine-induced hypoactivity in naive mice.
- Neither SCH23390 nor sulpiride blocked nicotine-induced antinociception.
Conclusions:
- Dopamine D1 and D2 receptors are not universally involved in all central effects of nicotine in mice.
- These dopamine receptors appear to mediate nicotine-induced locomotor activation specifically under conditions of prior habituation.
- The findings highlight the context-dependent role of the dopaminergic system in nicotine's behavioral pharmacology.